Immune Design Corp (IMDZ)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Carlos V. Paya
Employees:
50
1616 EASTLAKE AVENUE E., SUITE 310, SEATTLE, WA 98102
(650) 392-8350

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Immune Design Corp. is a clinical-stage immunotherapy company, which focuses on cancer with next-generation in vivo approaches designed to enable the body's immune system to fight disease. It includes products candidates from discovery platforms, IMDZVe or ZVex, and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Seattle, WA.

Data derived from most recent annual or quarterly report
Market Cap 282.937 Million Shares Outstanding48.365 Million Avg 30-day Volume 409.05 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.28
Price to Revenue28.6315 Debt to Equity0.0 EBITDA-56.143 Million
Price to Book Value0.6834 Operating Margin-2597.9053 Enterprise Value-33.012 Million
Current Ratio11.331 EPS Growth0.349 Quick Ratio10.921
1 Yr BETA 0.6872 52-week High/Low 0.0 / Profit Margin-2493.5337
Operating Cash Flow Growth-10.2584 Altman Z-Score-0.5727 Free Cash Flow to Firm -43.948 Million
View SEC Filings from IMDZ instead.

View recent insider trading info

Funds Holding IMDZ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IMDZ

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2019-02-21:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-01-08:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2018-12-10:
    Item 1.02: Termination of a Material Definitive Agreement
  • 8-K: filed on 2018-11-13:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2018-11-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-10-11:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-05-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-03-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-01-10:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2017-12-13:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    COLUMN GROUP L P

    COLUMN GROUP GP, LP

    COLUMN GROUP II, LP

    COLUMN GROUP II GP, LP

    PONOI CAPITAL, LP

    PONOI MANAGEMENT, LLC

    GOEDDEL DAVID V

    KUTZKEY TIM

    SVENNILSON PETER

    • 10% Owner
    • GENERAL PARTNER GENERAL PARTNER GENERAL PARTNERMANAGING PARTNERMANAGING PARTNERMANAGING PARTNER
    No longer subject to file 2019-04-02 0

    BALTIMORE DAVID

    • Director
    0 2019-04-02 0

    PENHOET EDWARD

    • Director
    0 2019-04-02 0

    COLEMAN LEWIS W

    • Director
    0 2019-04-02 0

    RINGO WILLIAM R

    • Director
    0 2019-04-02 0

    BERGER FRANKLIN M

    • Director
    0 2019-04-02 0

    KELLEY SUSAN L.

    • Director
    0 2019-04-02 0

    GOMBOTZ WAYNE CHIEF DEVELOPMENT OFFICER

    • Officer
    0 2019-04-02 0

    TER MEULEN JAN HENRIK CHIEF SCIENTIFIC OFFICER

    • Officer
    0 2019-04-02 0

    BRADY STEPHEN R EVP, STRATEGY & FINANCE

    • Officer
    0 2019-04-02 0

    PAYA CARLOS V PRESIDENT AND CEO

    • Officer
    • Director
    0 2019-04-02 0

    YURASOV SERGEY SR. VP, CLINIC. DEVEL. & CMO

    • Officer
    0 2019-04-02 0

    BVF PARTNERS L P/IL

    BIOTECHNOLOGY VALUE FUND L P

    BIOTECHNOLOGY VALUE FUND II LP

    BIOTECHNOLOGY VALUE TRADING FUND OS LP

    BVF PARTNERS OS LTD.

    BVF INC/IL

    LAMPERT MARK N

    • 10% Owner
    • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
    No longer subject to file 2018-12-04 0

    GUTHART LEO

    • 10% Owner
    5,664,739 2018-01-08 0

    SVENNILSON PETER

    • Director
    • 10% Owner
    0 2018-01-04 0

    COLUMN GROUP L P

    COLUMN GROUP GP, LP

    COLUMN GROUP II, LP

    COLUMN GROUP II GP, LP

    PONOI CAPITAL, LP

    PONOI MANAGEMENT, LLC

    GOEDDEL DAVID V

    KUTZKEY TIM

    • 10% Owner
    6,642,942 2017-10-27 0

    PONOI CAPITAL, LP

    PONOI MANAGEMENT, LLC

    KUTZKEY TIM

    • 10% Owner
    2,681,000 2017-10-27 0

    COLUMN GROUP L P

    COLUMN GROUP GP, LP

    COLUMN GROUP II, LP

    COLUMN GROUP II GP, LP

    GOEDDEL DAVID V

    • 10% Owner
    3,961,942 2016-09-20 0

    TOPSPIN FUND L.P.

    LG MANAGEMENT, LLC

    GUTHART LEO

    • 10% Owner
    3,098,239 2016-09-20 0

    COLUMN GROUP II, LP

    COLUMN GROUP II GP, LP

    • 10% Owner
    800,000 2016-09-20 0

    ATWOOD BRIAN G

    • Director
    0 2016-01-04 0

    KENNEY RICHARD T CHIEF MEDICAL OFFICER

    • Officer
    7,522 2016-01-04 0

    PROQUEST INVESTMENTS IV, L.P.

    PROQUEST ASSOCIATES IV LLC

    MOORIN JAY

    SCHREIBER ALAIN

    • 10% Owner
    No longer subject to file 2015-05-12 0

    RICKEY JAMES PAUL VP, FINANCE AND ADMINISTRATION

    • Officer
    0 2015-01-07 0

    COLUMN GROUP L P

    COLUMN GROUP GP, LP

    GOEDDEL DAVID V

    • 10% Owner
    3,161,942 2014-07-29 0

    ALTA PARTNERS VIII, L.P.

    ALTA PARTNERS MANAGEMENT VIII, LLC

    NOHRA GUY P

    JANNEY DANIEL

    CHAMPSI FARAH

    • 10% Owner
    2,482,775 2014-07-29 0

    VERSANT VENTURE CAPITAL III, L.P.

    VERSANT SIDE FUND III, L.P.

    • 10% Owner
    2,208,210 2014-07-29 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments